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Objective: Our study examines the association between suicidal ideation and and self-
reported symptoms of posttraumatic stress disorder (PTSD), major depressive disorder 
(MDD), generalized anxiety disorder (GAD), and alcohol use disorder (AUD) in a sample of 
treatment-seeking Canadian combat and peacekeeping veterans; and identifies potential 
predictors of suicidal ideation. 
Methods: Actively serving Canadian Forces and Royal Canadian Mounted Police members 
and veterans seeking treatment at the Parkwood Hospital Operational Stress Injury Clinic 
(n = 250) completed measures including the Primary Care Evaluation of Mental Disorders 
Patient Health Questionnaire, the Alcohol Use Disorder Identification Test, and the 
PTSD Checklist—Military Version (PCL-M) between January 2002 and December 2010. 
Regression analyses were used to determine the respective impact of PTSD, and self-
reported symptoms of MDD, GAD, AUD, and anxiety on suicidal ideation. 
Results: Most people met PCL-M screening criteria for PTSD (73.6%, n = 184), while 
70.8% (n = 177) screened positively for a probable major depressive episode. PTSD 
symptom was significantly associated with suicidal ideation (β = 0.412, P < 0.001). After 
controlling for self-reported depressive symptom severity, AUD severity, and generalized 
anxiety, PTSD severity was no longer significantly associated with suicidal ideation (β = 
0.043, P = 0.58). 
Conclusions: Although PTSD alone is associated with suicidal ideation, after controlling 
for common comorbid psychiatric illnesses, self-reported depressive symptom severity 
emerged as the most significant predictor of suicidal ideation. These findings support the 
importance of screening for comorbidities, particularly an MDD, as potentially modifiable 
conditions that are strongly related to suicidal ideation in military personnel’s endorsing 
criteria for PTSD.
W W W
Objectif : Notre étude examine l’association entre l’idéation suicidaire et les symptômes 
auto-déclarés du trouble de stress post-traumatique (TSPT), le trouble dépressif majeur 
(TDM), le trouble d’anxiété généralisée (TAG), et le trouble d’utilisation d’alcool (TUA) 
dans un échantillon d’anciens combattants canadiens de maintien de la paix et de combat 
suivant un traitement, et identifie les prédicteurs potentiels de l’idéation suicidaire. 
Méthodes : Des membres actifs et des anciens combattants des Forces canadiennes et 
de la Gendarmerie royale en traitement à la clinique Operational Stress Injury de l’hôpital 
Parkwood (n = 250) ont répondu à des instruments de mesure, notamment le questionnaire 
Posttraumatic Stress Disorder
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Abbreviations
AUD alcohol use disorder
AUDIT   Alcohol Use Disorder Identification Test
CAPS   Clinician-Administered PTSD Scale
CF   Canadian Forces
DSM   Diagnostic and Statistical Manual of Mental Disorders
GAD   generalized anxiety disorder
MDD   major depressive disorder
OEF   Operation Iraqi Freedom
OIF   Operation Enduring Freedom
PCL-M   PTSD Checklist—Military Version
PHQ   Patient Health Questionnaire
PSS-I   PTSD Symptom Scale—Interview Version
PTSD   posttraumatic stress disorder
RCMP   Royal Canadian Mounted Police
SCID   Structured Clinical Interview for DSM-IV
VAC Veterans Affairs Canada
Clinical Implications 
• Military personnel and veterans being assessed for 
treatment should be assessed for common comorbid 
psychiatric conditions that may complicate the treatment 
process. 
• The concurrent treatment of comorbid illnesses, such as 
MDD, may improve responses to treatment for PTSD.
Limitations
• Our study was limited to treatment-seeking military 
personnel and veterans, and may not be generalizable 
to broader military populations. 
• Our study relied on the use of self-report measures, 
which may differ from clinician-made diagnoses.
Peacekeeping and combat exposure is associated with an increased risk of developing a psychiatric disorder such 
as PTSD, depression, and (or) other anxiety disorders.1–3 
Lifetime prevalence of PTSD in military populations ranges 
between 9% and 30%.4–9 Commonly, PTSD co-occurs with 
other psychiatric disorders; in particular, MDD and AUD.10–
13 In veterans with a diagnosis of chronic military-related 
PTSD, about 50% also experience symptoms of comorbid 
MDD at some point in their lives.14 The endorsement of 
PTSD symptoms has been found to increase the risk of 
suicidal ideation and suicide attempts,15–20 while comorbid 
depression may further increase the risk for suicidal thoughts 
in veterans.21 Conversely, several studies have reported 
comorbid diagnoses of PTSD and depression are associated 
with lower completed suicide rates.22,23 In spite of these 
discrepant findings, understanding the relative influence of 
comorbid conditions on suicidal ideation in veterans with 
PTSD could ultimately contribute to decreased mortality 
and morbidity.
Research on suicidal ideation among military personnel 
suggests that currently serving military members and 
veterans with a psychiatric disorder may be at a greater risk 
of having suicidal ideation or behaviours when compared 
with their civilian counterparts or veterans without any 
psychiatric diagnoses.24–28 Previous research demonstrates 
that exposure to traumatic events increases the risk of 
engaging in suicidal behaviours,29–31 and that number 
of lifetime traumatic events experienced is associated 
with suicidal behaviours.32 Studies of American military 
populations have demonstrated that suicide rates among 
active duty US military members deployed to OIF and OEF 
increased almost 2-fold from the beginning of 2001.33 These 
American military veterans are more than twice as likely to 
die by suicide than members of the general population.34 A 
recent report from the Center for a New American Security 
indicated a record number of suicides had occurred among 
active US Army members and reservists in July 2011, and 
that an estimated 18 US veterans die daily from completed 
suicide.35 Another study found that members of the 
Australian Defence Force were significantly more likely to 
experience suicidal ideation than members of the Australian 
general population (3.9% and 1.7%, respectively).36
PTSD is associated with decreased quality of life, 
increased medical comorbidity, and increased psychosocial 
impairment,37–40 and military members with PTSD often 
experience a greater need for health care services.41 The 
presence of comorbid psychiatric diagnoses may exacerbate 
impaired psychosocial functioning and quality of life, with 
sur la santé du patient et l’évaluation des troubles mentaux dans les soins de première ligne, le test 
d’identification du trouble d’utilisation d’alcool, et la liste de vérification du TSPT — version militaire (PCL-M) 
entre janvier 2002 et décembre 2010. Des analyses de régression ont servi à déterminer l’effet respectif du 
TSPT, des symptômes auto-déclarés du TDM, TAG, TUA, et de l’anxiété sur l’idéation suicidaire.  
Résultats : La plupart des personnes ont satisfait aux critères de dépistage du PCL-M pour le TSPT 
(73,6 %, n = 184), tandis que 70,8 % (n = 177) avaient un résultat positif d’un épisode dépressif majeur 
probable. Les symptômes du TSPT étaient significativement associés à l’idéation suicidaire (β = 0,412,  
P < 0,001). Après un contrôle de la gravité des symptômes dépressifs auto-déclarés, de la gravité du TUA, et 
de l’anxiété généralisée, la gravité du TSPT n’était plus significativement associée à l’idéation suicidaire  
(β = 0,043, P = 0,58). 
Conclusions : Bien que le TSPT à lui seul soit associé à l’idéation suicidaire, après un contrôle des maladies 
psychiatriques communément comorbides, la gravité des symptômes dépressifs auto-déclarés ressortait 
comme étant le prédicteur le plus significatif de l’idéation suicidaire. Ces résultats soulignent l’importance de 
dépister les comorbidités, particulièrement un TDM, comme conditions possiblement modifiables qui sont 
fortement liées à l’idéation suicidaire chez le personnel militaire qui satisfait aux critères du TSPT. 
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further increase in the cost of PTSD for both the person 
and society.42 To alleviate this burden, timely and accurate 
mental health assessments and treatment are a necessity.
The clinical task of predicting which people may be at 
an increased risk of completing suicide is a complex and 
challenging care issue. Identifying risk factors for suicidal 
ideation, an established correlate with suicide completion, 
has the potential to help clinicians identify people who may 
require further screening and focused interventions. Given 
the importance of early identification and management of 
suicidal ideation in veterans with PTSD, the objectives 
of our study are: to examine the association between 
self-reported suicidal ideation and PTSD, self-reported 
symptoms of depression, alcohol misuse, and GAD in 
a sample of treatment-seeking veterans; and to identify 
potential predictors of suicidal ideation.
Methods
Participants and Procedure
Participants consisted of a convenience sample of 250 
currently serving CF and RCMP members and veterans 
referred by their primary care physician, VAC—Area 
Counsellor, or RCMP Case Manager, to the Parkwood 
Hospital Operational Stress Injury outpatient clinic for 
a voluntary comprehensive assessment between January 
2002 and December 2010. The Parkwood Operational 
Stress Injury Clinic is 1 of 10 specialized clinics funded by 
VAC to treat veterans with psychiatric disorders, such as 
PTSD resulting from military operation.
The clinic follows a standardized assessment screening 
protocol which includes the PHQ,43 the PCL-M,44 the 
AUDIT,45 the Short-Form Health Survey-36,46 and the Brief 
Traumatic Brain Injury Screen.47 At intake to the Operational 
Stress Injury Clinic, participants provided informed consent 
for information collected from psychological measures 
administered during their initial assessment to be used for 
clinical review, education, and outcome measurement. The 
data from intake assessments are de-identified and stored 
in an electronic database. Our study obtained its data from 
this previously collected dataset and received approval 
for its use from both the Office of Research Ethics of The 
University of Western Ontario and the relevant hospital 
ethics review board.
Measures
The AUDIT45 is a 10-item, self-administered measure that 
may be used to identify people at an increased risk for 
hazardous or harmful patterns of alcohol consumption, 
including alcohol dependence. Eight items are scored 
using a Likert-type scale from 0 to 4, while the final 2 
items pertain to alcohol-related problems, with more recent 
problems receiving greater weight than problems earlier in 
life. Items are summed to derive a total score (range = 0 to 
40). Greater AUDIT scores indicate greater risk for problem 
drinking, with a score of 8 or higher considered indicative 
of hazardous alcohol consumption. Greater AUDIT scores 
indicate greater risk for problem drinking, with a score 
of 8 or higher considered indicative of hazardous alcohol 
consumption and probable AUD.45
The PHQ43 is a self-administered version of the Primary 
Care Evaluation of Mental Disorders. This measure 
screens for threshold and subthreshold mood, anxiety, and 
somatoform disorders.43 The PHQ also includes a brief 
measure known as the PHQ-9 that was used to screen for 
the presence or absence of MDD, as well as depressive 
symptom severity and suicidal ideation in our study. The 
PHQ-9 assesses 3 depressive symptom clusters: mood, 
physical, and cognitive; the role of symptom severity 
of each of these clusters was also assessed in our study. 
The PHQ-9 diagnostic scoring algorithm corresponds to 
DSM-IV MDD requirements, wherein 5 or more items must 
be experienced “in the past 2 weeks” at least “more than half 
the days” with at least 1 of these symptoms being depressed 
mood or diminished interest or anhedonia.48 The PHQ-9 has 
demonstrated good internal reliability (Cronbach α = 0.89) 
and test–retest reliability (r = 0.84).48 For our study, 
suicidality on the PHQ-9 was defined as an endorsement of 
“several days” or more to the PHQ-9 item (“Thoughts that 
you would be better off dead or of hurting yourself in some 
way”). The PHQ-9 suicidality item was removed from total 
PHQ-9 scores to reduce artificial inflation of the association 
between MDD and suicidal ideation, and was instead used 
as an independent measure of suicidal ideation. Used alone, 
the PHQ-9 suicide screening item has a demonstrated 
specificity of 0.84 and sensitivity of 0.69.10
The PCL-M44 is a self-administered, 17-item scale that is 
used to assess self-reported PTSD symptom severity related 
to a military-specific traumatic experience. Respondents 
rate how affected they have been by each of 17 symptoms 
belonging to the 3 DSM-IV symptom clusters (that is, 
re-experiencing, avoidance and numbing, and hyperarousal) 
during the past month using a 5-point Likert-type scale. 
Total scores are tabulated by summing all 17-item responses, 
with higher scores representing greater symptom severity 
(range = 17 to 85). A score of 50 or greater is typically 
considered a positive screen for PTSD in populations 
similar to particpants in our study.44,49–52
Diagnoses of PTSD were confirmed in a clinical assessment 
using an empirically supported PTSD interview53,54: either 
the CAPS,55 the SCID Axis I Disorders PTSD module,56 or 
the PSS-I.57 The CAPS is a 30-item structured interview that 
can be used to assess both current (past month) and lifetime 
PTSD. In addition to assessing the 17 symptoms measured 
in the PCL-M, the CAPS also evaluates the impact of 
these symptoms on social and occupational functioning, as 
well as PTSD symptom severity and improvement, if any, 
since a previous CAPS administration.58 The SCID is a 
semi-structured clinical interview tool that uses diagnostic 
criteria from the DSM-IV along with a categorical system 
for rating the frequency and severity of symptoms and a 
scoring algorithm to determine the absence or presence 
(either full or subthreshold) of an Axis I diagnosis such as 
PTSD.59 The PSS-I is a 17-item, semi-structured interview 
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that assesses the presence, frequency, and severity of PTSD 
symptoms related to a single identified traumatic event. 
Foa and Tolin60 have used all 3 of these assessment tools 
to demonstrate that the PSS-I and CAPS have comparable 
internal consistency coefficients (Cronbach α = 0.65–0.86 
for the PSS-I and 0.71–0.85 for the CAPS) and that the 
total scores of all 3 measures are highly correlated with one 
another (Spearman correlation coefficient ρ = 0.73–0.83, 
P < 0.01).
Data Analysis
Data for our study was analyzed using SPSS 17.0 statistical 
package (PASW, Chicago, IL). Descriptive statistics 
were used to determine the frequency of 4 self-reported 
psychiatric illnesses: PTSD, MDD, GAD, alcohol misuse, 
and associated suicidal ideation. PTSD was measured using 
the PCL-M and confirmed using the CAPS, SCID, or PSS-I, 
while probable MDD, GAD, and suicidal ideation were 
measured using the PHQ. Alcohol misuse was measured 
using the AUDIT. In model 1, linear regression analyses 
were conducted to determine if total PCL-M scores were 
significantly associated with suicidal ideation. In model 
2, both PTSD symptom severity (total PCL-M scores) 
and absence or presence of probable GAD were entered. 
In model 3, PTSD symptom severity and alcohol misuse 
severity (AUDIT scores) were entered. In model 4, PTSD 
symptom severity and depressive symptom severity 
(PHQ-9 scores) were entered. In the final model, PTSD 
symptom severity, absence or presence of GAD, alcohol 
misuse severity, and depressive symptom severity were 
entered. Other variables, such as depression, as well as 
deployment to Afghanistan, were included in regression 
analyses. The 5 regression models were then repeated using 
only participants who had been deployed to Afghanistan. 
Another set of linear regression analyses were conducted 
to determine whether individual items on the PCL-M 
were predictive of suicidal ideation. In this analysis, all 
17 PCL-M items were entered into the model in a single 
block. This analysis was then repeated controlling for 
depressive symptom severity. Finally, PHQ-9 depressive 
symptom clusters (that is, mood, physical, and cognitive) 
were entered into a final linear regression analysis in a 
single block. Missing values were imputed using the item 
mean for all participants, as this method is computationally 
simple and using listwise deletion may have compromised 
the statistical power of the study.
Results
Demographics
The vast majority of participants (n = 193; 77.2%) were 
veterans released from the CF, while 55 (22.0%) were 
actively serving in the CF. Only 2 participants (0.8%) were 
RCMP members. Participants had served an average of 15.0 
years (SD 9.0) in the CF or RCMP, and had been deployed 
an average of 3 times (SD 6.87). About one-quarter of the 
sample (n = 65, 26.0%) had been deployed to Afghanistan 
at least once. The majority of participants (n = 231; 92.4%) 
were male. The mean age of participants included in the 
final sample was 41.75 years (SD 10.29). Participant ages 
ranged from 20 to 65 years.
The prevalence of self-reported probable psychiatric 
condition is depicted in Figure 1. The majority (n = 184, 
73.6%) of the sample met PCL-M criteria for probable 
PTSD, and almost three-quarters (n = 177, 70.8%) screened 
positive for probable MDD on the PHQ. About two-thirds 
of the sample also screened positive for probable GAD 
on the PHQ. One-third had an AUDIT score of at least 
8, indicating a significantly increased risk for hazardous 
alcohol consumption. Among the participants who met 
PCL-M criteria for probable PTSD, only 4.4% (n = 8) 
did not screen positive for another psychiatric disorder. 
The percentage of participants who screened positive 
for probable comorbid MDD, GAD, AUD, and suicidal 
ideation is provided in Figure 2. Among the total sample, 
slightly more than one-half of participants reported that they 
Figure 1  Frequencies of self-reported probable psychiatric disorders and suicidal 
ideation
%
        PTSD          MDD            GAD              AUD           Suicidal        Suicidal 
                                                                                        ideation        ideation 
                                                                                        (several      (>half the 
                                                                                          days)            days)
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experienced no thoughts of self-harm or that they would be 
better off dead during the past 2 weeks (n = 135; 54.0%), 
while about one-quarter reported experiencing these kinds 
of thoughts for several days (n = 58; 23.2%). Another 16.8% 
(n = 42) reported experiencing thoughts of self-harm more 
than one-half of the days of the past 2 weeks, while 6.0% 
(n = 15) reported feeling this way nearly every day during 
the previous 2 weeks.
Imputation of Missing Data
Missing values were imputed for total AUDIT scores 
in 2 instances and PHQ-9 total score in an additional 20 
instances.
Predictors of Suicidal Ideation
In regression analyses, total PCL-M scores were significantly 
associated with suicidal ideation (β = 0.412, P < 0.001). After 
controlling for probable GAD and alcohol misuse severity, 
the association between total PCL-M score and suicidal 
ideation remained significant (P < 0.001). However, after 
controlling for self-reported depressive symptom severity, 
total PCL-M scores were no longer significantly associated 
with suicidal ideation (β = 0.064, P = 0.4). Instead, self-
reported depressive symptom severity emerged as the 
most significant predictor of suicidal ideation (P < 0.001; 
Table 1).
Additional analyses were conducted on a subsample of 
people who had been deployed to Afghanistan (n = 65) to 
determine whether any differences existed between those 
who had been deployed on a recent combat mission and 
the sample as a whole. Similar to the rest of the sample, 
total PCL-M scores were significantly associated with 
suicidal ideation and remained significant after controlling 
for probable GAD (β = 0.366, P = 0.01) and alcohol misuse 
severity (β = 0.425, P = 0.001), but not after controlling for 
self-reported depressive symptom severity (β = 0.240, P = 
0.21). After examining all potential predictors, self-reported 
depressive symptom severity emerged as the strongest 
predictor of suicidal ideation in the Afghanistan-only 
subsample (Table 2). Independent variables were identified 
as statistically significant predictors in the final step, when 
all diagnoses were included in the model.
Table 1  Effect of PTSD symptom severity, absence or presence of GAD, AUD severity, 
and depressive symptom severity on suicidal ideation among entire cohort of CF 
members and veterans
Model β t df P
1 Total PCL-M score 0.412 7.117 247 <0.001
2 Total PCL-M score 0.373 5.961 246 <0.001
GAD 0.101 1.606 0.11
3 Total PCL-M score 0.404 6.903 244 <0.001
AUD severity 0.031 0.527 0.60
4 Total PCL-M score 0.064 0.850 224 0.40
Depressive symptom severity 0.528 6.964 <0.001
5 Total PCL-M score 0.043 0.552 221 0.58
GAD –0.001 0.020 0.98
AUD severity 0.105 1.903 0.06
Depressive symptom severity 0.541 7.003 <0.001
Figure 2  Frequency of comorbid self-reported MDD, GAD, AUD, and suicidal 
ideation
        MDD              GAD                AUD              Suicidal         Suicidal 
                                                                           ideation         ideation 
                                                                           (several         (>half the 
                                                                              days)            days)
%
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To determine whether numerous individual items from 
the PCL-M were reliable predictors of suicidal ideation, 
supplemental regression analyses were conducted (Table 3). 
The PCL-M items 11 (that is, “Feeling emotionally numb or 
being unable to have loving feelings for those close to you”) 
and 12 (that is, “Feeling as if your future will somehow be 
cut short”) were strongly associated with suicidal ideation 
and remained statistically significant even after controlling 
for self-reported depressive symptom severity (P = 0.47 
and 0.003, respectively). The PCL-M item 3 (“Suddenly 
acting or feeling as if a stressful military experience were 
happening again”) was also significantly associated with 
suicidal ideation. Controlling for self-reported depressive 
symptom severity, the association was no longer statistically 
significant at the P < 0.5 level. PHQ-9 symptom clusters 
(that is, mood, cognitive, and physical) were also explored 
as predictors of suicidal ideation. Only the PHQ-9 mood 
cluster was significant at the P < 0.05 level (Table 3).
Discussion
Consistent with previous reported research findings,24,61 
PTSD severity was associated with increased suicidal 
ideation among treatment-seeking veterans in our study. 
Despite the well-documented relation between PTSD and 
suicidal ideation,24,61 significant controversy persists in 
the literature regarding the relative contribution of PTSD 
and its associated comorbidities to the occurrence of 
Table 2  Effect of PTSD symptom severity, absence or presence of GAD, AUD 
severity, and depressive symptom severity on suicidal ideation among CF members 
and veterans deployed to Afghanistan
Model β t df P
1 Total PCL-M score 0.436 3.840 62 <0.001
2 Total PCL-M score 0.366 2.546 61 0.01
GAD 0.115 0.798 0.43
3 Total PCL-M score 0.425 3.674 61 0.001
AUD severity 0.060 0.518 0.61
4 Total PCL-M score 0.240 1.271 61 0.21
Depressive symptom severity 0.243 1.285 0.20
5 Total PCL-M score 0.186 0.920 59 0.36
GAD 0.068 0.460 0.65
AUD severity 0.080 0.680 0.50
Depressive symptom severity 0.242 1.215 0.23
Table 3  Regression analyses of individual PCL-M items, PHQ-9 symptom clusters, and depressive 
symptom severity
Model β t df P
1 PCL-M item 3 (suddenly acting or feeling as if 
a stressful military experience were happening 
again)
0.192 2.133 205 0.03
PCL-M item 11 (feeling emotionally numb or 
being unable to have loving feelings for those 
close to you)
0.182 2.225 0.03
PCL-M item 12 (feeling as if future will be cut 
short)
0.327 4.221 <0.001
2 PCL-M item 3 (suddenly acting or feeling as if 
a stressful military experience were happening 
again)
0.149 1.713 204 0.09
PCL-M item 11 (feeling emotionally numb or 
being unable to have loving feelings for those 
close to you)
0.158 2.000 0.047
PCL-M item 12 (feeling as if future will be cut 
short)
0.231 2.982 0.003
Depressive symptom severity 0.393 4.324 <0.001
3 PHQ-9 mood symptom cluster 0.434 4.676 220 <0.001
PHQ-9 physical symptom cluster 0.095 1.037 0.30
PHQ-9 cognitive symptom cluster 0.099 1.272 0.20
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concomitant suicidal ideation. Our results were similar to 
those reported by Marshall et al,15 who reported that the 
number of PTSD symptoms was associated with suicidal 
ideation. This is clinically important as it demonstrates that 
even participants who may not meet the full diagnostic 
criteria for PTSD may also be at a higher risk of having 
suicidal ideation. Additionally, patients whose symptoms 
do not meet full diagnostic criteria for PTSD may still 
experience significant functional impairment.15
Most participants screened positive for more than one 
probable psychiatric condition in the current treatment-
seeking sample. Among participants who screened positive 
for PTSD on the PCL-M, 85.9% screened positive for 
probable MDD on the PHQ-9. This finding is consistent 
with another recent study24 on PTSD and associated suicidal 
ideation in a military population that reported about 50% 
of a sample of Ohio Army National Guard soldiers with 
a diagnosis of PTSD in the past year were also diagnosed 
with MDD. The higher rate of comorbid MDD observed in 
our study may be related to the treatment-seeking nature of 
our sample.
When controlling for self-reported depressive symptom 
severity as the most common comorbid condition, PTSD 
was no longer associated with suicidal ideation. This 
finding is consistent with a recent meta-analysis62 that also 
concluded, when controlling for comorbid conditions such 
as major depression, it attenuated the association between 
PTSD and suicidal ideation. However, the findings of 
our study are in contrast to a recent study of US military 
veterans deployed during OEF and (or) OIF,63 as well as 
a treatment-seeking OIF and OEF veteran population,64 
that reported PTSD was associated with increased suicidal 
ideation despite controlling for comorbid MDD. This 
discrepancy in findings between studies may be explained 
by the differences in the strictly combat sample of the OIF 
and OEF studies, compared with the mixed combat and 
peacekeeping sample of our study.
The findings of our study emphasize the importance of 
assessing for comorbidity, especially MDD, and to screen 
for suicidal ideations when assessing veterans for PTSD. 
Both MDD and subsyndromal depressive symptoms 
are significant components of suicidal risk features for 
which potentially effective interventions are available 
that may mitigate against this risk.65,66 As psychotherapy 
and pharmacotherapy have demonstrated poor response 
in military-related PTSD when compared with civilian 
PTSD,67–70 treating comorbidity, especially MDD, may 
improve patients’ responses to psychotherapy.32,71
Although our study adds to the dearth of literature on 
the relation between self-reported psychiatric illness 
and suicidal ideation in treatment-seeking Canadian 
peacekeeping and combat veterans with PTSD, there are 
numerous limitations. Our study examined veterans seeking 
treatment at a single site and at a specialized tertiary care 
clinic. The uniqueness of our study’s treatment setting may 
limit the generalizability of these findings being applied to 
veterans seeking care from a more general mental health 
care service. Further, the design of our study does not allow 
for causal relations to be evaluated. Additionally, even 
though self-rating measures such as the PCL-M and PHQ 
have been extensively used in research to identify cases of 
PTSD and other psychiatric conditions,72–75 discrepancies 
between the outcomes of self-report measures and clinician-
made diagnoses may exist.
Conclusions
In this sample of actively serving CF and RCMP members 
and veterans seeking treatment, PTSD alone appeared to be 
closely associated with suicidal ideation. However, when 
controlling for the most common comorbid psychiatric 
illness, probable MDD and self-reported depressive 
symptom severity emerged as the most significant predictor 
of suicidal ideation. Our study emphasizes the importance 
of considering comorbidity, especially depression, when 
evaluating for military-related PTSD.
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